← Back to all articles

Cartiva Synthetic Cartilage Implant Lawsuits: Product Liability and Accountability for Medical Device Failures

By Adam J. Langino, Esq.

Cartiva Synthetic Cartilage Implant Lawsuits: Product Liability and Accountability for Medical Device Failures

The Cartiva Synthetic Cartilage Implant was introduced as a medical device intended to relieve pain and restore mobility for patients suffering from arthritis in the big toe joint. Marketed as a motion‑preserving alternative to joint fusion surgery, the implant was positioned as a long‑term solution that could reduce pain without sacrificing movement.

In recent years, however, patients across the country have reported serious complications following Cartiva implantation, including device failure, worsening pain, and the need for additional surgeries. These outcomes have led to product liability lawsuits alleging that the Cartiva implant was defectively designed, inadequately tested, or marketed without sufficient warnings.

What Is the Cartiva Synthetic Cartilage Implant?

The Cartiva implant is a synthetic device designed to be placed in the first metatarsophalangeal joint at the base of the big toe. It was developed to treat hallux rigidus, a degenerative condition that limits joint motion and causes pain.

The device was promoted as a way to preserve joint motion while reducing arthritis pain, offering an alternative to traditional treatments such as joint fusion. According to litigation filings and patient reports, many individuals chose the Cartiva implant specifically to avoid the permanent loss of movement associated with fusion surgery.

Reported Complications and Device Failures

Patients who later filed Cartiva implant lawsuits have described a range of serious complications, including:

  • Persistent or increased pain following implantation

  • Loosening or displacement of the implant

  • Bone erosion or joint deterioration

  • Loss of joint stability

  • Need for revision surgery, often resulting in joint fusion

For some patients, revision surgery caused exactly the outcome the device was marketed to avoid: permanent fusion of the big toe joint and reduced mobility.

Allegations Raised in Cartiva Implant Lawsuits

Cartiva implant lawsuits assert that injuries were not simply the result of individual medical outcomes, but rather of systemic product failures. Common allegations include:

Defective Design

Claims allege that the implant’s material properties and design made it prone to failure once implanted, particularly under normal forces experienced during walking and daily activity.

Inadequate Testing

Plaintiffs allege the device was introduced to the market without adequate long‑term clinical testing to support claims of durability and effectiveness.

Failure to Warn

Lawsuits also allege that patients and surgeons were not adequately warned of the risk of premature failure, loosening, or the high likelihood of revision surgery.

Misleading Marketing

Some claims assert that the device was marketed as a motion‑preserving alternative despite data suggesting higher‑than‑expected failure rates.

Federal Litigation and the MDL Process

Cartiva implant cases have been centralized in federal multidistrict litigation. MDL proceedings are designed to coordinate pretrial discovery when lawsuits share common factual questions, such as product design, testing, regulatory submissions, and warning labels.

Centralization reflects a determination that Cartiva lawsuits raise overlapping issues regarding the device’s safety, approval process, and post‑market performance. While MDL proceedings do not decide liability, they play a significant role in developing evidence and shaping the path toward potential resolution.

Product Liability Law and Defective Medical Devices

Under product liability law, manufacturers of medical devices have a duty to design, test, and market their products in a manner that is reasonably safe for intended use. Claims involving defective medical devices typically fall into three categories:

  • Design defects, where the product is unreasonably dangerous due to its design

  • Manufacturing defects, where a product deviates from its intended design

  • Failure to warn, where known risks are not adequately disclosed

Medical device cases are often complex and evidence‑driven, requiring expert testimony regarding engineering, biomechanics, regulatory compliance, and clinical performance.

Why Cartiva Implant Claims Are Complex

Cartiva implant lawsuits are not typical personal injury cases. They involve technical medical evidence, corporate decision‑making, and regulatory scrutiny. Key issues may include:

  • What testing was conducted before the device entered the market

  • What data the manufacturer possessed regarding failure rates

  • How risks were communicated to surgeons and patients

  • Whether alternative designs or warnings could have reduced harm

These cases often require careful reconstruction of the device’s development and post‑market history.

Product Liability Representation at Langino Law PLLC

Langino Law PLLC represents individuals harmed by defective and unreasonably dangerous products, including medical devices. Product liability cases demand thorough investigation, expert analysis, and a willingness to hold manufacturers accountable when safety obligations are not met.

Medical device litigation often involves sophisticated defendants and extensive discovery. Effective representation requires experience navigating technical evidence and complex legal frameworks.

Potential Eligibility for Cartiva Implant Claims

Individuals may have potential claims if they:

  • Received a Cartiva Synthetic Cartilage Implant

  • Experienced ongoing pain, loosening, or device failure

  • Required revision surgery, including joint fusion

  • Were not adequately warned of the risk of failure

Each case depends on specific medical and factual circumstances and should be evaluated individually.

The Cartiva Synthetic Cartilage Implant was marketed as an innovative solution for joint pain, but patient reports and litigation allege that the device failed to perform as promised for many users. When a medical device causes harm due to defective design or insufficient warnings, product liability law provides a mechanism to examine what went wrong and who should be held responsible.

Contact Langino Law PLLC

Langino Law PLLC represents individuals harmed by defective medical devices and other dangerous products throughout North Carolina and beyond. For a free, confidential consultation, call 888‑254‑3521 or visit https://www.langinolaw.com/contact.

Miller, Ronald V., Jr. Cartiva Implant Lawsuit: 2026 Update on Litigation and Settlement. Lawsuit Information Center, Feb. 10, 2026.

Langino Law PLLC. Product Liability. Langino Law PLLC Practice Areas.